Molecular Dissection Of Aberrant Il6/Gp130 And Tgfb Signaling In The Pathogenesis Of Interstitial Pneumonitis

Grant number: 1025239 | Funding period: 2012 - 2014



Interstitial pneumonia (IP) is frequently observed in the group of lung diseases which affect the transfer of oxygen from inhaled air into the bloodstream. Current treatments for these diseases only effectively manage patient’s symptoms but don’t cure patients of IP. We have developed a strategy to identify the exact cell type responsible for an acute IP and the molecular intermediates that may offer novel treatments and pave the way for a possible cure for this disease.